Stilla raises 31M euros in financing

By The Science Advisory Board staff writers

Stilla Technologies has secured 31 million euros (about $35 million) in financing in the form of convertible bonds. The new funds will be used to further develop Stilla's global commercial presence and its next-generation digital polymerase chain reaction platform, the six-color Naica system, which it recently released.

In addition to new funding from existing investors Illumina Ventures, Kurma Partners, TusPark Capital Management, LBO France, BNP Paribas Developpement, and Eurazeo, Stilla attracted investment from life science firm Casdin Capital and the European Investment Bank.

Copyright © 2021

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?